Discharge order verification process to reduce prescription errors and optimize diabetes management

IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Marissa J. Cavaretta, Rabya Mirza , Joseph T. Finn, Timothy Trumbower, Josephine Luong
{"title":"Discharge order verification process to reduce prescription errors and optimize diabetes management","authors":"Marissa J. Cavaretta,&nbsp;Rabya Mirza ,&nbsp;Joseph T. Finn,&nbsp;Timothy Trumbower,&nbsp;Josephine Luong","doi":"10.1016/j.japh.2025.102354","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Prescription errors at discharge have a detrimental impact on patients, especially in high-risk populations like those with diabetes mellitus (DM). A team-based, patient-centered approach has been shown to reduce medication errors and improve patient outcomes. To address this, an inpatient pharmacist-driven initiative was implemented, focusing on a discharge order verification process to review and intervene on antidiabetic prescriptions before they are e-prescribed.</div></div><div><h3>Objective</h3><div>The objective was to evaluate the effectiveness of a discharge order verification process in improving the prescribing of antidiabetic medications and supplies for DM patients before e-prescriptions are transmitted to community pharmacies.</div></div><div><h3>Methods</h3><div>This proof of concept study ran over 4 weeks and included adult patients with a diagnosis of DM and who had at least one discharge order for the management of DM. Orders populated into a discharge verification queue built into the electronic health record (EHR) system. When an order was received, an investigator pharmacist reviewed the chart to determine appropriateness, evaluating medication safety, effectiveness, and accessibility. Interventions to address drug-related problems were made in real-time. Once verified, e-prescriptions were transmitted to community pharmacies. Pharmacist interventions were quantified and categorized. Data was collected on the intervention type, proportion of patients discharged on an optimized regimen, length of time an order remained in the queue, interventions unlikely to be detected without EHR access, and intervention acceptance and execution.</div></div><div><h3>Results</h3><div>Overall, 152 orders were verified on 63 patients. Thirty-eight patients (60.3%) had at least one order requiring intervention, totaling 56 interventions made overall. The most common interventions were additional drug necessary (17.9%), counseling required (16.1%), incorrect instructions (16.1%), and dosing adjustment (14.3%). Twenty-eight patients (73.7%) left on a newly optimized medication regimen.</div></div><div><h3>Conclusion</h3><div>This service model introduced a discharge order verification process for pharmacists to review and intervene on antidiabetic prescriptions before transmission to a community pharmacy. Pharmacist interventions effectively corrected errors, with a high rate of provider acceptance and execution of recommendations.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"65 3","pages":"Article 102354"},"PeriodicalIF":2.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmacists Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1544319125000330","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Prescription errors at discharge have a detrimental impact on patients, especially in high-risk populations like those with diabetes mellitus (DM). A team-based, patient-centered approach has been shown to reduce medication errors and improve patient outcomes. To address this, an inpatient pharmacist-driven initiative was implemented, focusing on a discharge order verification process to review and intervene on antidiabetic prescriptions before they are e-prescribed.

Objective

The objective was to evaluate the effectiveness of a discharge order verification process in improving the prescribing of antidiabetic medications and supplies for DM patients before e-prescriptions are transmitted to community pharmacies.

Methods

This proof of concept study ran over 4 weeks and included adult patients with a diagnosis of DM and who had at least one discharge order for the management of DM. Orders populated into a discharge verification queue built into the electronic health record (EHR) system. When an order was received, an investigator pharmacist reviewed the chart to determine appropriateness, evaluating medication safety, effectiveness, and accessibility. Interventions to address drug-related problems were made in real-time. Once verified, e-prescriptions were transmitted to community pharmacies. Pharmacist interventions were quantified and categorized. Data was collected on the intervention type, proportion of patients discharged on an optimized regimen, length of time an order remained in the queue, interventions unlikely to be detected without EHR access, and intervention acceptance and execution.

Results

Overall, 152 orders were verified on 63 patients. Thirty-eight patients (60.3%) had at least one order requiring intervention, totaling 56 interventions made overall. The most common interventions were additional drug necessary (17.9%), counseling required (16.1%), incorrect instructions (16.1%), and dosing adjustment (14.3%). Twenty-eight patients (73.7%) left on a newly optimized medication regimen.

Conclusion

This service model introduced a discharge order verification process for pharmacists to review and intervene on antidiabetic prescriptions before transmission to a community pharmacy. Pharmacist interventions effectively corrected errors, with a high rate of provider acceptance and execution of recommendations.
出院单验证流程,减少处方错误,优化糖尿病管理。
背景:出院时的处方错误对患者有不利的影响,特别是对糖尿病(DM)等高危人群。以团队为基础,以患者为中心的方法已被证明可以减少用药错误并改善患者预后。为了解决这个问题,实施了一项住院药剂师驱动的倡议,重点关注出院单验证过程,以便在电子处方之前审查和干预降糖药处方。目的:目的是评估出院单验证流程在改善糖尿病患者在电子处方传播到社区药房之前开具抗糖尿病药物和用品的有效性。方法:这项概念验证研究持续了4周,纳入了诊断为糖尿病且至少有一个糖尿病管理出院单的成年患者。这些出院单被填充到电子健康记录(EHR)系统内的出院验证队列中。当收到订单时,调查员药剂师审查表格以确定适当性,评估药物的安全性、有效性和可及性。实时采取干预措施解决与毒品有关的问题。一经核实,电子处方就被传送到社区药房。对药师干预措施进行量化和分类。收集的数据包括干预类型、按优化方案出院的患者比例、一个订单在队列中停留的时间、在没有电子病历访问的情况下不可能检测到的干预措施、以及干预措施的接受和执行情况。结果:63例患者共验证订单152条。38名患者(60.3%)至少有一个顺序需要干预,总共56个干预。最常见的干预措施是需要额外的药物(17.9%)、需要咨询(16.1%)、不正确的指导(16.1%)和剂量调整(14.3%)。28例患者(73.7%)选择了新优化的用药方案。结论:该服务模式引入出院单审核流程,药师可在将降糖药处方传递给社区药房前对其进行审核和干预。药师干预有效地纠正了错误,提供者接受和执行建议的率很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
14.30%
发文量
336
审稿时长
46 days
期刊介绍: The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信